Voyager Therapeutics, Inc. (VYGR) Income Annual - Discounting Cash Flows
VYGR
Voyager Therapeutics, Inc.
VYGR (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
Report Filing 2025-11-10 2025-03-11 2023-12-31 2023-03-07 2022-03-08 2021-02-25 2020-03-03 2019-02-26 2018-03-14 2017-03-15 2016-03-17 2014-12-31 2013-12-31
Revenue 31.32 80 250 40.91 37.41 171.1 104.4 7.62 10.13 14.22 17.33 0 0
Cost of Revenue 0 0 92.17 55.76 73.79 108.8 119.7 64.91 62.26 42.25 27.68 8.9 4.63
Gross Profit 31.32 80 157.8 -14.86 -36.37 62.38 -15.34 -57.29 -52.12 -28.03 -10.35 -8.9 -4.63
Operating Expenses 171.5 163.3 35.82 35.98 37.25 34.99 36.34 33.81 19.74 13.27 9.91 5.47 2.9
Research & Development 134.3 127.4 92.17 60.76 73.79 108.8 119.7 64.91 62.26 42.25 27.68 8.9 4.63
Selling, General and Administrative 37.22 35.92 35.82 30.98 37.25 34.99 36.34 33.81 19.74 13.27 9.91 5.47 2.9
Other Operating Expenses 0 0 -92.17 -55.76 -73.79 -108.8 -119.7 -64.91 -62.26 -42.25 -27.68 -8.9 -4.63
Operating Income -140.2 -83.29 122 -50.84 -73.62 27.38 -51.68 -91.09 -71.86 -41.3 -20.25 -14.37 -7.53
Net Non-Operating Interest 12.5 18.33 11.72 1.79 0 1.66 6.46 3.31 1.23 -0.976 -0.332 0 0.134
Interest Income 12.5 18.33 11.72 1.79 0 1.66 6.46 3.31 1.23 0 0 0 0.134
Interest Expense 0 0 0 0 0 0 0 0 0 0.976 0.332 0 0
Equity & Other Income/(Expense) 1.65 0.622 0.003 2.65 2.42 7.7 1.62 -0.683 -0.062 2.13 -9.09 -1.95 -0.268
Income Before Tax -126.1 -64.34 133.7 -46.39 -71.2 36.74 -43.6 -88.47 -70.7 -40.14 -29.67 -16.32 -7.67
Income Tax Expense 0.719 0.665 1.41 0.016 0 0 0 -0.18 0 0.052 0 0 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income -126.8 -65 132.3 -46.41 -71.2 36.74 -43.6 -88.29 -70.7 -40.19 -29.67 -16.32 -7.67
Depreciation and Amortization 4.02 4.73 4.44 6.19 5.17 3.82 2.77 2.12 1.59 0.612 0.6 0.184 7.53
EBITDA -136.2 -78.56 126.5 -44.65 -68.45 31.2 -48.91 -88.98 -70.27 -40.69 -19.65 -14.18 0
Earnings Per Share (EPS) -2.16 -1.13 3.08 -1.21 -1.75 0.99 -1.14 -2.75 -2.64 -1.59 -7.08 -1.11 -16.55
Diluted Earnings Per Share -2.16 -1.13 2.97 -1.21 -1.75 0.98 -1.14 -2.75 -2.64 -1.59 -7.08 -1.11 -16.55
Weighted Average Shares Outstanding 58.8 57.67 43.02 38.36 37.67 37.13 35.9 32.07 26.8 25.3 4.19 14.71 0.463
Diluted Weighted Average Shares Outstanding 58.8 57.67 44.57 38.36 37.67 37.35 35.9 32.07 26.8 25.3 4.19 14.71 0.463
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program